These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure. Milionis HJ; Elisaf MS; Tselepis A; Bairaktari E; Karabina SA; Siamopoulos KC Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198 [TBL] [Abstract][Full Text] [Related]
9. Decrease of Lp(a) during weight reduction in obese children is modified by the apo(a) kringle-IV copy number variation. Brandstätter A; Lingenhel A; Zwiauer K; Strobl W; Kronenberg F Int J Obes (Lond); 2009 Oct; 33(10):1136-42. PubMed ID: 19636317 [TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure. Sechi LA; Zingaro L; Catena C; Perin A; De Marchi S; Bartoli E Kidney Int; 1999 Sep; 56(3):1049-57. PubMed ID: 10469373 [TBL] [Abstract][Full Text] [Related]
11. Pentanucleotide repeat and size polymorphisms in the apolipoprotein(a) gene are associated with the lipoprotein(a) concentration in chronic hemodialysis patients. Tanaka M; Yanagi H; Ando R; Kurihara S; Hirano C; Kobayashi K; Kikuchi S; Hamaguchi H; Tsuchiya S; Tomura S Nephron; 1999; 81(4):414-20. PubMed ID: 10095177 [TBL] [Abstract][Full Text] [Related]
12. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). Dieplinger H; Lackner C; Kronenberg F; Sandholzer C; Lhotta K; Hoppichler F; Graf H; König P J Clin Invest; 1993 Feb; 91(2):397-401. PubMed ID: 8432847 [TBL] [Abstract][Full Text] [Related]
13. Reduction of lipoprotein(a) following treatment with lovastatin in patients with unremitting nephrotic syndrome. Brown CD; Azrolan N; Thomas L; Roberts KG; Bostom A; Zhao ZH; Friedman EA Am J Kidney Dis; 1995 Jul; 26(1):170-7. PubMed ID: 7611249 [TBL] [Abstract][Full Text] [Related]
17. Lipoprotein(a) in the nephrotic syndrome: molecular analysis of lipoprotein(a) and apolipoprotein(a) fragments in plasma and urine. Doucet C; Mooser V; Gonbert S; Raymond F; Chapman J; Jacobs C; Thillet J J Am Soc Nephrol; 2000 Mar; 11(3):507-513. PubMed ID: 10703674 [TBL] [Abstract][Full Text] [Related]
18. Apo(a) phenotypes and lp(a) concentrations in renal transplant patients. Kandoussi AM; Hugue V; Cachera C; Hazzan M; Dracon M; Tacquet A; Noël C Nephron; 1998 Oct; 80(2):183-7. PubMed ID: 9736817 [TBL] [Abstract][Full Text] [Related]
19. Apo(a) isoforms do not predict risk for coronary heart disease in a Gulf Arab population. Akanji AO Ann Clin Biochem; 2000 May; 37 ( Pt 3)():360-6. PubMed ID: 10817252 [TBL] [Abstract][Full Text] [Related]
20. Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1). Dieplinger H; Kronenberg F Wien Klin Wochenschr; 1999 Jan; 111(1):5-20. PubMed ID: 10067265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]